Brain region-specific altered expression and association of mitochondria-related genes in autism

Molecular Autism

Volumn 3, Issue 1, 2012, Pages

  Anitha, Ayyappan ^a   Nakamura, Kazuhiko ^b   Thanseem, Ismail ^b   Yamada, Kazuo ^c   Iwayama, Yoshimi ^c   Toyota, Tomoko ^c   Matsuzaki, Hideo ^a   Miyachi, Taishi ^a   Yamada, Satoru ^d   Tsujii, Masatsugu ^a,e   Tsuchiya, Kenji J ^a   Matsumoto, Kaori ^a   Iwata, Yasuhide ^b   Suzuki, Katsuaki ^a   Ichikawa, Hironobu ^d   Sugiyama, Toshiro ^b   Yoshikawa, Takeo ^c   Mori, Norio ^a,b  

^a Molecular Research Center for Children's Mental Development   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^d TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^e CHUKYO UNIVERSITY   (Japan)

Author keywords

Autism; Metaxin; Mitochondria; NEFL; Postmortem brain; Uncoupling protein

Indexed keywords

NEUROFILAMENT PROTEIN;

ANTERIOR CINGULATE; APOPTOSIS; ARTICLE; AUTISM; BIOGENESIS; BRAIN REGION; BRAIN TISSUE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; JAPANESE; MITOCHONDRIAL GENE; MOTOR CORTEX; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; THALAMUS;

EID: 84871510790     PISSN: None     EISSN: 20402392     Source Type: Journal    
DOI: 10.1186/2040-2392-3-12     Document Type: Article

References (87)

1. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, United States 2006. Rice C, MMWR Surveill Summ 2009 58 1 20 20023608
2. A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes. Minshew NJ, Goldstein G, Dombrowski SM, Panchalingam K, Pettegrew JW, Biol Psychiatry 1993 33 762 773 10.1016/0006-3223(93)90017-8 8373914 (Pubitemid 23234627)
3. Evidence of altered energy metabolism in autistic children. Chugani DC, Sundram BS, Behen M, Lee ML, Moore GJ, Prog Neuropsychopharmacol Biol Psychiatry 1999 23 635 641 10.1016/S0278-5846(99)00022-6 10390722 (Pubitemid 29268408)
4. Autism: a mitochondrial disorder? Lombard J, Med Hypotheses 1998 50 497 500 10.1016/S0306-9877(98)90270-5 9710323 (Pubitemid 28307912)
5. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Schwab MA, Sauer SW, Okun JG, Nijtmans LG, Rodenburg RJ, van den Heuvel LP, Drose S, Brandt U, Hoffmann GF, Ter Laak H, Kolker S, Smeitink JA, Biochem J 2006 398 107 112 10.1042/BJ20060221 16686602 (Pubitemid 44231305)
6. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp KP, Behav Brain Res 2007 176 149 169 10.1016/j.bbr.2006.07.025 16950524 (Pubitemid 44895353)
7. A novel rodent model of autism: intraventricular infusions of propionic acid increase locomotor activity and induce neuroinflammation and oxidative stress in discrete regions of adult rat brain. MacFabe DF, Rodriguez-Captoe K, Hoffman JE, Franklin AE, Mohammed-Asef Y, Taylor AR, Boon F, Cain DP, Kavaliers M, Possmayer F, Ossenkopp K, Am J Biochem Biotech 2008 4 146 166 (Pubitemid 351573649)
8. Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autism. Shultz SR, MacFabe DF, Ossenkopp KP, Scratch S, Whelan J, Taylor R, Cain DP, Neuropharmacology 2008 54 901 911 10.1016/j.neuropharm. 2008.01.013 18395759
9. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Rossignol DA, Frye RE, Mol Psychiatry 2012 17 290 314 10.1038/mp.2010.136 21263444
10. Mitochondrial dysfunction in autism. Giulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, Hertz-Picciotto I, Tassone F, Pessah IN, JAMA 2010 304 2389 2396 10.1001/jama.2010.1706 21119085
11. Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. Fillano JJ, Goldenthal MJ, Rhodes CH, Marin-Garcia J, J Child Neurol 2002 17 435 439 10.1177/088307380201700607 12174964 (Pubitemid 35012139)
12. Mitochondrial energy-deficient endophenotype in autism. Gargus JJ, Imtiaz F, Am J Biochem Biotech 2008 4 198 207 (Pubitemid 351573653)
13. Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Filipek PA, Juranek J, Smith M, Mays LZ, Ramos ER, Bocian M, Masser-Frye D, Laulhere TM, Modahl C, Spence MA, Gargus JJ, Ann Neurol 2003 53 801 804 10.1002/ana.10596 12783428 (Pubitemid 36622519)
14. Autistic disorder in 2 children with mitochondrial disorders. Tsao CY, Mendell JR, J Child Neurol 2007 22 1121 1123 10.1177/0883073807306266 17890412 (Pubitemid 47412687)
15. 5q14.3 deletion manifesting as mitochondrial disease and autism: case report. Ezugha H, Goldenthal M, Valencia I, Anderson CE, Legido A, Marks H, J Child Neurol 2010 25 1232 1235 10.1177/0883073809361165 20179003
16. Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. Chauhan A, Gu F, Essa MM, Wegiel J, Kaur K, Brown WT, Chauhan V, J Neurochem 2011 117 209 220 10.1111/j.1471-4159.2011. 07189.x 21250997
17. Brain transcriptional and epigenetic associations with autism. Ginsberg MR, Rubin RA, Falcone T, Ting AH, Natowicz MR, PLoS One 2012 7 44736 10.1371/journal.pone.0044736 22984548
18. SLC25A12 expression is associated with neurite outgrowth and is upregulated in the prefrontal cortex of autistic subjects. Lepagnol-Bestel AM, Maussion G, Boda B, Cardona A, Iwayama Y, Delezoide AL, Moalic JM, Muller D, Dean B, Yoshikawa T, Gorwood P, Buxbaum JD, Ramoz N, Simonneau M, Mol Psychiatry 2008 13 385 397 10.1038/sj.mp.4002120 18180767 (Pubitemid 351399819)
19. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Palmieri L, Papaleo V, Porcelli V, Scarcia P, Gaita L, Sacco R, Hager J, Rousseau F, Curatolo P, Manzi B, Militerni R, Bravaccio C, Trillo S, Schneider C, Melmed R, Elia M, Lenti C, Saccani M, Pascucci T, Puglisi-Allegra S, Reichelt KL, Persico AM, Mol Psychiatry 2010 15 38 52 10.1038/mp.2008.63 18607376
20. Altered levels of Bcl2 and p53 proteins in parietal cortex reflect deranged apoptotic regulation in autism. Fatemi SH, Halt AR, Synapse 2001 42 281 284 10.1002/syn.10002 11746727 (Pubitemid 33027302)
21. Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects. Araghi-Niknam M, Fatemi SH, Cell Mol Neurobiol 2003 23 945 952 14964781 (Pubitemid 38063334)
22. The autism genetic resource exchange: a resource for the study of autism and related neuropsychiatric conditions. Geschwind DH, Sowinski J, Lord C, Iversen P, Shestack J, Jones P, Ducat L, Spence SJ, Am J Hum Genet 2001 69 463 466 10.1086/321292 11452364 (Pubitemid 32695220)
23. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Lord C, Rutter M, Le Couteur A, J Autism Dev Disord 1994 24 659 685 10.1007/BF02172145 7814313 (Pubitemid 24309810)
24. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fourth edition, Text Revision Washington, DC: American Psychiatric Association 2000
25. American Psychiatric Association, User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders SCID-1: Clinician Version Washington, DC: American Psychiatric Association 1997 23198003
26. High-throughput genotyping with single nucleotide polymorphisms. Ranade K, Chang MS, Ting CT, Pei D, Hsiao CF, Olivier M, Pesich R, Hebert J, Chen YD, Dzau VJ, Curb D, Olshen R, Risch N, Cox DR, Botstein D, Genome Res 2001 11 1262 1268 11435409 (Pubitemid 32677301)
27. Emotional and behavioral correlates of the anterior cingulate cortex during associative learning in rats. Takenouchi K, Nishijo H, Uwano T, Tamura R, Takigawa M, Ono T, Neuroscience 1999 93 1271 1287 10.1016/S0306-4522(99)00216-X 10501451 (Pubitemid 29397555)
28. Cognitive and emotional influences in anterior cingulate cortex. Bush G, Luu P, Posner MI, Trends Cogn Sci 2000 4 215 222 10.1016/S1364-6613(00)01483-2 10827444 (Pubitemid 30332147)
29. Role of motor cortex in voluntary movements in primates. Evarts EV, Handbook of Physiology-The Nervous System, II Maryland: American Physiological Society, Brookhart JM, Mountcastle VB, 1981 1083 1120
30. Sensory gating mechanisms of the thalamus. McCormick DA, Bal T, Curr Opin Neurobiol 1994 4 550 556 10.1016/0959-4388(94)90056-6 7812144 (Pubitemid 24258915)
31. Reduced cognitive control of response inhibition by the anterior cingulate cortex in autism spectrum disorders. Agam Y, Joseph RM, Barton JJ, Manoach DS, NeuroImage 2010 52 336 347 10.1016/j.neuroimage.2010.04.010 20394829
32. Annotation: the neural basis of social impairments in autism: the role of the dorsal medial-frontal cortex and anterior cingulate system. Mundy P, J Child Psychol Psychiatry 2003 44 793 809 10.1111/1469-7610.00165 12959489 (Pubitemid 37059217)
33. Autism is characterized by dorsal anterior cingulate hyperactivation during social target detection. Dichter GS, Felder JN, Bodfish JW, Soc Cogn Affect Neurosci 2009 4 215 226 10.1093/scan/nsp017 19574440
34. Response monitoring, repetitive behaviour and anterior cingulate abnormalities in autism spectrum disorders (ASD). Thakkar KN, Polli FE, Joseph RM, Tuch DS, Hadjikhani N, Barton JJ, Manoach DS, Brain 2008 131 2464 2478 10.1093/brain/awn099 18550622
35. Increased motor cortex white matter volume predicts motor impairment in autism. Mostofsky SH, Burgess MP, Gidley Larson JC, Brain 2007 130 2117 2122 10.1093/brain/awm129 17575280 (Pubitemid 47236619)
36. Neuropsychologic functioning in autism: profile of a complex information processing disorder. Minshew NJ, Goldstein G, Siegel DJ, J Int Neuropsychol Soc 1997 3 303 316 9260440 (Pubitemid 27351144)
37. Reduced thalamic volume in high-functioning individuals with autism. Tsatsanis KD, Rourke BP, Klin A, Volkmar FR, Cicchetti D, Schultz RT, Biol Psychiatry 2003 53 121 129 10.1016/S0006-3223(02)01530-5 12547467 (Pubitemid 36126474)
38. Immune transcriptome alterations in the temporal cortex of subjects with autism. Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, Mirnics K, Persico AM, Neurobiol Dis 2008 30 303 311 10.1016/j.nbd.2008.01.012 18378158
39. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH, Nature 2011 474 380 384 10.1038/nature10110 21614001
40. A genome-wide search for alleles and haplotypes associated with autism and related pervasive developmental disorders on the Faroe Islands. Lauritsen MB, Als TD, Dahl HA, Flint TJ, Wang AG, Vang M, Kruse TA, Ewald H, Mors O, Mol Psychiatry 2006 11 37 46 10.1038/sj.mp.4001754 16205737 (Pubitemid 43251086)
41. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer. Tabares-Seisdedos R, Rubenstein JL, Mol Psychiatry 2009 14 563 589 10.1038/mp.2009.2 19204725
42. Neurofilaments are intrinsic determinants of axonal caliber. Muma NA, Hoffman PN, Micron 1993 24 677 683 10.1016/0968-4328(93)90044-2 (Pubitemid 2043110)
43. Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content. Elder GA, Friedrich VL Jr, Bosco P, Kang C, Gourov A, Tu PH, Lee VM, Lazzarini RA, J Cell Biol 1998 141 727 739 10.1083/jcb.141.3.727 9566972 (Pubitemid 28217917)
44. Sensorimotor and cognitive function of a NEFL(P22S) mutant model of Charcot-Marie-Tooth disease type 2E. Filali M, Dequen F, Lalonde R, Julien JP, Behav Brain Res 2011 219 175 180 10.1016/j.bbr.2010.12.022 21168446
45. Mechanisms of mitochondria-neurofilament interactions. Wagner OI, Lifshitz J, Janmey PA, Linden M, McIntosh TK, Leterrier JF, J Neurosci 2003 23 9046 9058 14534238 (Pubitemid 37243805)
46. Normal role of the low-molecular-weight neurofilament protein in mitochondrial dynamics and disruption in Charcot-Marie-Tooth disease. Gentil BJ, Minotti S, Beange M, Baloh RH, Julien JP, Durham HD, FASEB J 2012 26 1194 1203 10.1096/fj.11-196345 22155564
47. UCP4, a novel brain-specific mitochondrial protein that reduces membrane potential in mammalian cells. Mao W, Yu XX, Zhong A, Li W, Brush J, Sherwood SW, Adams SH, Pan G, FEBS Lett 1999 443 326 330 10.1016/S0014-5793(98)01713-X 10025957 (Pubitemid 29080820)
48. Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress. Liu D, Chan SL, de Souza-Pinto NC, Slevin JR, Wersto RP, Zhan M, Mustafa K, de Cabo R, Mattson MP, Neuromolecular Med 2006 8 389 414 10.1385/NMM:8:3:389 16775390
49. The brain uncoupling protein UCP4 attenuates mitochondrial toxin-induced cell death: role of extracellular signal-regulated kinases in bioenergetics adaptation and cell survival. Wei Z, Chigurupati S, Bagsiyao P, Henriquez A, Chan SL, Neurotox Res 2009 16 14 29 10.1007/s12640-009-9039-8 19526295
50. Overexpression of uncoupling protein 4 promotes proliferation and inhibits apoptosis and differentiation of preadipocytes. Zhang M, Wang B, Ni YH, Liu F, Fei L, Pan XQ, Guo M, Chen RH, Guo XR, Life Sci 2006 79 1428 1435 10.1016/j.lfs.2006.04.012 16716360
51. Comparative analysis of uncoupling protein 4 distribution in various tissues under physiological conditions and during development. Smorodchenko A, Rupprecht A, Sarilova I, Ninnemann O, Brauer AU, Franke K, Schumacher S, Techritz S, Nitsch R, Schuelke M, Pohl EE, Biochim Biophys Acta 2009 1788 2309 2319 10.1016/j.bbamem.2009.07.018 19646951
52. Mitochondrial uncoupling proteins in the CNS: in support of function and survival. Andrews ZB, Diano S, Horvath TL, Nat Rev Neurosci 2005 6 829 840 10.1038/nrn1767 16224498 (Pubitemid 41568725)
53. Mitochondrial uncoupling protein-4 regulates calcium homeostasis and sensitivity to store depletion-induced apoptosis in neural cells. Chan SL, Liu D, Kyriazis GA, Bagsiyao P, Ouyang X, Mattson MP, J Biol Chem 2006 281 37391 37403 10.1074/jbc.M605552200 17035241 (Pubitemid 46042043)
54. Fatty acid interaction with mitochondrial uncoupling proteins. Jezek P, J Bioenerg Biomembr 1999 31 457 466 10.1023/A:1005496306893 10653474 (Pubitemid 30053959)
55. Fatty acid activation of the uncoupling proteins requires the presence of the central matrix loop from UCP1. Jimenez-Jimenez J, Ledesma A, Zaragoza P, Gonzalez-Barroso MM, Rial E, Biochim Biophys Acta 2006 1757 1292 1296 10.1016/j.bbabio.2006.05.027 16814247 (Pubitemid 44442127)
56. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM, Ann Neurol 2004 55 576 580 10.1002/ana.20062 15048898 (Pubitemid 38391976)
57. Metaxin is a component of a preprotein import complex in the outer membrane of the mammalian mitochondrion. Armstrong LC, Komiya T, Bergman BE, Mihara K, Bornstein P, J Biol Chem 1997 272 6510 6518 10.1074/jbc.272.10.6510 9045676 (Pubitemid 27118131)
58. Metaxin 1 interacts with metaxin 2, a novel related protein associated with the mammalian mitochondrial outer membrane. Armstrong LC, Saenz AJ, Bornstein P, J Cell Biochem 1999 74 11 22 10.1002/(SICI)1097-4644(19990701)74: 1<11::AID-JCB2>3.0.CO;2-V 10381257 (Pubitemid 29270023)
59. Metaxin deficiency alters mitochondrial membrane permeability and leads to resistance to TNF-induced cell killing. Ono K, Wang X, Kim SO, Armstrong LC, Bornstein P, Han J, Protein Cell 2010 1 161 173 10.1007/s13238-010-0017-y 21088703
60. Crucial role of the membrane potential for ATP synthesis by F(1)F(o) ATP synthases. Dimroth P, Kaim G, Matthey U, J Exp Biol 2000 203 51 59 10600673 (Pubitemid 30079069)
61. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Nicholls DG, Ward MW, Trends Neurosci 2000 23 166 174 10.1016/S0166-2236(99)01534-9 10717676 (Pubitemid 30151213)
62. The axonal transport of mitochondria. Hollenbeck PJ, Saxton WM, J Cell Sci 2005 118 5411 5419 10.1242/jcs.02745 16306220 (Pubitemid 43079283)
63. Control of mitochondrial transport and localization in neurons. MacAskill AF, Kittler JT, Trends Cell Biol 2010 20 102 112 10.1016/j.tcb.2009.11.002 20006503
64. The mitochondrial transporter family (SLC25): physiological and pathological implications. Palmieri F, Pflugers Arch 2004 447 689 709 10.1007/s00424-003-1099-7 14598172 (Pubitemid 38241455)
65. Mitochondrial aspartate/glutamate carrier SLC25A12 gene is associated with autism. Turunen JA, Rehnstrom K, Kilpinen H, Kuokkanen M, Kempas E, Ylisaukko-Oja T, Autism Res 2008 1 189 192 10.1002/aur.25 19360665
66. Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. Correia C, Coutinho AM, Diogo L, Grazina M, Marques C, Miguel T, Ataide A, Almeida J, Borges L, Oliveira C, Oliveira G, Vicente AM, J Autism Dev Disord 2006 36 1137 1140 10.1007/s10803-006-0138-6 17151801 (Pubitemid 46020366)
67. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Ramoz N, Reichert JG, Smith CJ, Silverman JM, Bespalova IN, Davis KL, Buxbaum JD, Am J Psychiatry 2004 161 662 669 10.1176/appi.ajp.161.4.662 15056512 (Pubitemid 38445510)
68. Targeting proteins into mitochondria. Douglas MG, McCammon MT, Vassarotti A, Microbiol Rev 1986 50 166 178 2941675 (Pubitemid 16090326)
69. The protein import machinery of mitochondria. Wiedemann N, Frazier AE, Pfanner N, J Biol Chem 2004 279 14473 14476 10.1074/jbc.R400003200 14973134 (Pubitemid 38618831)
70. Mitochondrial fission and fusion dynamics: the long and short of it. Berman SB, Pineda FJ, Hardwick JM, Cell Death Differ 2008 15 1147 1152 10.1038/cdd.2008.57 18437161 (Pubitemid 351850967)
71. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Li Z, Okamoto K, Hayashi Y, Sheng M, Cell 2004 119 873 887 10.1016/j.cell.2004.11.003 15607982 (Pubitemid 40017692)
72. Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neurons. Li H, Chen Y, Jones AF, Sanger RH, Collis LP, Flannery R, McNay EC, Yu T, Schwarzenbacher R, Bossy B, Bossy-Wetzel E, Bennett MV, Pypaert M, Hickman JA, Smith PJ, Hardwick JM, Jonas EA, Proc Natl Acad Sci USA 2008 105 2169 2174 10.1073/pnas.0711647105 18250306 (Pubitemid 351439483)
73. A human dynamin-related protein controls the distribution of mitochondria. Smirnova E, Shurland DL, Ryazantsev SN, van der Bliek AM, J Cell Biol 1998 143 351 358 10.1083/jcb.143.2.351 9786947 (Pubitemid 28487855)
74. Control of mitochondrial morphology by a human mitofusin. Santel A, Fuller MT, J Cell Sci 2001 114 867 874 11181170 (Pubitemid 32266258)
75. Atypical Rho GTPases have roles in mitochondrial homeostasis and apoptosis. Fransson A, Ruusala A, Aspenstrom P, J Biol Chem 2003 278 6495 6502 10.1074/jbc.M208609200 12482879 (Pubitemid 36800910)
76. Autism spectrum disorder is related to endoplasmic reticulum stress induced by mutations in the synaptic cell adhesion molecule, CADM1. Fujita E, Dai H, Tanabe Y, Zhiling Y, Yamagata T, Miyakawa T, Tanokura M, Momoi MY, Momoi T, Cell Death Dis 2010 1 47 10.1038/cddis.2010.23 21364653
77. Association of upregulated Ras/Raf/ERK1/2 signaling with autism. Zou H, Yu Y, Sheikh AM, Malik M, Yang K, Wen G, Chadman KK, Brown WT, Li X, Genes Brain Behav 2011 10 615 624 10.1111/j.1601-183X.2011.00702.x 21595826
78. Neurologic presentations of mitochondrial disorders. Nissenkorn A, Zeharia A, Lev D, Watemberg N, Fattal-Valevski A, Barash V, Gutman A, Harel S, Lerman-Sagie T, J Child Neurol 2000 15 44 48 10.1177/088307380001500110 10641610 (Pubitemid 30056888)
79. Mitochondrial dysfunction in autism spectrum disorders: cause or effect? Palmieri L, Persico AM, Biochim Biophys Acta 2010 1797 1130 1137 10.1016/j.bbabio.2010.04.018 20441769
80. Autism and mitochondrial disease. Haas RH, Dev Disabil Res Rev 2010 16 144 153 10.1002/ddrr.112 20818729
81. Pre- and postmortem influences on brain RNA. Barton AJ, Pearson RC, Najlerahim A, Harrison PJ, J Neurochem 1993 61 1 11 7685811 (Pubitemid 23175878)
82. Effect of RNA quality on transcript intensity levels in microarray analysis of human post-mortem brain tissues. Popova T, Mennerich D, Weith A, Quast K, BMC Genomics 2008 9 91 10.1186/1471-2164-9-91 18298816 (Pubitemid 351420411)
83. Myers RM: Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Li JZ, Vawter MP, Walsh DM, Tomita H, Evans SJ, Choudary PV, Lopez JF, Avelar A, Shokoohi V, Chung T, Mesarwi O, Jones EG, Watson SJ, Akil H, Bunney WE Jr, Hum Mol Genet 2004 13 609 616 10.1093/hmg/ddh065 14734628 (Pubitemid 38379850)
84. Inhibition of oxidative phosphorylation in hepatic and cerebral mitochondria of sodium valproate-treated rats. Rumbach L, Warter JM, Rendon A, Marescaux C, Micheletti G, Waksman A, J Neurol Sci 1983 61 417 423 10.1016/0022-510X(83)90174-0 6418862 (Pubitemid 14234269)
85. Effects of tricyclic antidepressant drugs on energy-linked reactions in mitochondria. Weinbach EC, Costa JL, Nelson BD, Claggett CE, Hundal T, Bradley D, Morris SJ, Biochem Pharmacol 1986 35 1445 1451 10.1016/0006-2952(86)90108-5 2939836 (Pubitemid 16037997)
86. Seizure-induced changes in mitochondrial redox status. Liang LP, Patel M, Free Radic Biol Med 2006 40 316 322 10.1016/j.freeradbiomed.2005.08.026 16413413 (Pubitemid 43069355)
87. Prolonged seizure activity impairs mitochondrial bioenergetics and induces cell death. Kovac S, Domijan AM, Walker MC, Abramov AY, J Cell Sci 2012 125 1796 1806 10.1242/jcs.099176 22328526